569 related articles for article (PubMed ID: 19303506)
1. Thrombolytic therapy for deep vein thrombosis: potential application of plasmin.
Marder VJ
Thromb Res; 2009; 123 Suppl 4():S56-61. PubMed ID: 19303506
[TBL] [Abstract][Full Text] [Related]
2. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
[TBL] [Abstract][Full Text] [Related]
3. Locally delivered plasmin: why should it be superior to plasminogen activators for direct thrombolysis?
Novokhatny VV; Jesmok GJ; Landskroner KA; Marder VJ; Zimmerman TP
Trends Pharmacol Sci; 2004 Feb; 25(2):72-5. PubMed ID: 15102492
[TBL] [Abstract][Full Text] [Related]
4. Splenic and superior mesenteric artery thrombolytic infusion therapy for acute portal and mesenteric vein thrombosis.
Safieddine N; Mamazza J; Common A; Prabhudesai V
Can J Surg; 2007 Feb; 50(1):68-9. PubMed ID: 17391622
[No Abstract] [Full Text] [Related]
5. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
Skeik N; Gits CC; Ehrenwald E; Cragg AH
Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
[TBL] [Abstract][Full Text] [Related]
6. Locally applied recombinant plasmin results in effective thrombolysis in a porcine model of arteriovenous graft thrombosis.
Hoefer IE; Stroes ES; Pasterkamp G; Levi MM; Reekers JA; Verhagen HJ; Meijers JC; Humphries JE; Rotmans JI
J Vasc Interv Radiol; 2009 Jul; 20(7):951-8. PubMed ID: 19481472
[TBL] [Abstract][Full Text] [Related]
7. Safety of catheter-directed thrombolysis for deep venous thrombosis in cancer patients.
Kim HS; Preece SR; Black JH; Pham LD; Streiff MB
J Vasc Surg; 2008 Feb; 47(2):388-94. PubMed ID: 18241762
[TBL] [Abstract][Full Text] [Related]
8. Haemostatic safety of a unique recombinant plasmin molecule lacking kringles 2-5.
Marder VJ; Manyak S; Gruber T; Goyal A; Moreno G; Hunt J; Bromirski J; Scuderi P; Petteway SR; Novokhatny V
Thromb Haemost; 2010 Oct; 104(4):780-7. PubMed ID: 20806125
[TBL] [Abstract][Full Text] [Related]
9. Assessing the outcome of systemic tissue plasminogen activator for the management of venous and arterial thrombosis in pediatrics.
Newall F; Browne M; Savoia H; Campbell J; Barnes C; Monagle P
J Pediatr Hematol Oncol; 2007 Apr; 29(4):269-73. PubMed ID: 17414572
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator.
Lee K; Istl A; Dubois L; DeRose G; Forbes TL; Wiseman D; Mujoomdar A; Kribs S; Power AH
Vasc Endovascular Surg; 2015 Oct; 49(7):175-9. PubMed ID: 26462979
[TBL] [Abstract][Full Text] [Related]
11. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children.
Gupta AA; Leaker M; Andrew M; Massicotte P; Liu L; Benson LN; McCrindle BW
J Pediatr; 2001 Nov; 139(5):682-8. PubMed ID: 11713447
[TBL] [Abstract][Full Text] [Related]
12. Treatment of superior mesenteric and portal vein thrombosis with direct thrombolytic infusion via an operatively placed mesenteric catheter.
Kaplan JL; Weintraub SL; Hunt JP; Gonzalez A; Lopera J; Brazzini A
Am Surg; 2004 Jul; 70(7):600-4. PubMed ID: 15279182
[TBL] [Abstract][Full Text] [Related]
13. The case for thrombolysis for iliofemoral venous thrombosis.
Peden E; Zhou W; Bush RL; Lumsden AB; Lin PH
Semin Vasc Surg; 2005 Sep; 18(3):139-47. PubMed ID: 16168889
[TBL] [Abstract][Full Text] [Related]
14. Safety of catheter-delivered plasmin in patients with acute lower extremity arterial or bypass graft occlusion: phase I results.
Marder VJ; Comerota AJ; Shlansky-Goldberg RD; Davis JP; Deng C; Hanna K; Fineberg D
J Thromb Haemost; 2012 Jun; 10(6):985-91. PubMed ID: 22487025
[TBL] [Abstract][Full Text] [Related]
15. Initial clinical results of tenecteplase (TNK) in catheter-directed thrombolytic therapy.
Razavi MK; Wong H; Kee ST; Sze DY; Semba CP; Dake MD
J Endovasc Ther; 2002 Oct; 9(5):593-8. PubMed ID: 12431142
[TBL] [Abstract][Full Text] [Related]
16. Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis.
Smalberg JH; Spaander MV; Jie KS; Pattynama PM; van Buuren HR; van den Berg B; Janssen HL; Leebeek FW
Thromb Haemost; 2008 Dec; 100(6):1084-8. PubMed ID: 19132234
[TBL] [Abstract][Full Text] [Related]
17. Thrombolysis for stroke in the over 80s.
Ford GA
Age Ageing; 2004 Mar; 33(2):95-7. PubMed ID: 14960420
[No Abstract] [Full Text] [Related]
18. Safety and efficacy of catheter directed thrombolysis in children with deep venous thrombosis.
Darbari DS; Desai D; Arnaldez F; Desai K; Kallen J; Strouse J; Streiff MB; Hong K; Takemoto CM
Br J Haematol; 2012 Nov; 159(3):376-8. PubMed ID: 22934795
[No Abstract] [Full Text] [Related]
19. Development of catheter-directed intrathrombus thrombolysis with plasmin for the treatment of acute lower extremity arterial occlusion.
Comerota AJ
Thromb Res; 2008; 122 Suppl 3():S20-6. PubMed ID: 18701142
[TBL] [Abstract][Full Text] [Related]
20. Safety of plasmin in the setting of concomitant aspirin and heparin administration in an animal model of bleeding.
Sadeghi S; Marder VJ; Stewart D; Kong M; Humphries J; Baumbach GA; Jesmok G
J Thromb Haemost; 2003 Dec; 1(12):2621-5. PubMed ID: 14675099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
